Eli Lilly Launches 10 Suits Over New Diabetes Drug
A little more than a year after releasing a popular billion-dollar drug marketed at people with Type 2 diabetes, Eli Lilly & Co. filed a flurry of lawsuits on Tuesday against...To view the full article, register now.
Already a subscriber? Click here to view full article